Sarcopenia: why strength matters, not only muscle mass

Low muscle strength is often considered a key sign that something may be wrong functionally. Muscle quantity matters, but it does not tell the whole story.

A person can have lower functional strength even when body composition does not look dramatically bad. The opposite can also happen: muscle quantity changes slowly while strength changes with training, illness, fatigue or inactivity.

Grip strength is useful because it is quick, repeatable and connected with broader functional status in many clinical and research contexts.

InBody gives the structural layer: fat-free mass, skeletal muscle mass, segments and water. InGrip gives a functional output: how much force is produced in a standardized grip test.

Together, they provide broader context than a muscle-mass estimate alone. Neither device can establish the cause of low strength or confirm sarcopenia.

A concerning result can support a decision to seek broader professional assessment or to monitor change under comparable conditions.

Repeated low strength, falling muscle mass, unwanted weight loss, weakness, frequent falls, pain or functional decline deserve attention. In those situations, the measurement should be treated as a prompt for broader assessment.

Strength training is often important, but it is not a universal answer for every situation. Energy intake, protein, illness, medication, recovery and movement safety all matter.

If there are health concerns, the next step should be individualized.

EWGSOP2 places low muscle strength first as an indicator of probable sarcopenia. Low muscle quantity or quality is needed to confirm it, and poor physical performance indicates greater severity. A low InBody muscle value alone is therefore not the diagnosis.

The European consensus uses grip below 27 kg for men and below 16 kg for women as low-strength thresholds in the appropriate assessment setting. These are not universal fitness targets. Age, population, health, pain and the measurement protocol must be considered.

The newer GLIS global consensus describes low muscle mass and strength together in a conceptual definition and treats impaired physical performance as a possible outcome. That publication did not set one clinical diagnostic algorithm or device-specific cut-offs; the grip thresholds above come from EWGSOP2.

Aging, prolonged inactivity, hospital admission, illness, substantial weight loss and inadequate intake are reasons to pay attention to function as well as muscle quantity. Record right and left grip, body-composition estimates and everyday tasks such as walking and rising from a chair.

A visit cannot explain the cause of weakness. Frequent falls, worsening walking, unwanted weight loss, neurological symptoms, pain or rapid functional decline should lead to healthcare assessment, not just another fitness measurement or an unsupervised exercise prescription.